Tiago Fleming Outeiro, Ph.D.
Affiliations: | Neuroscience Unit, Institute of Molecular Medicine | University of Lisbon, Lisboa, Lisboa, Portugal |
Area:
models of neurodegenerative disease, sreeningGoogle:
"Tiago Outeiro"Mean distance: 15.78 | S | N | B | C | P |
Parents
Sign in to add mentorSusan L. Lindquist | grad student | 1999-2004 | Whitehead Institute for Biomedical Research (FlyTree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
da Silva ANR, Pereira GRC, Bonet LFS, et al. (2024) In silico analysis of alpha-synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry |
Quesnel A, Martin LD, Tarzi C, et al. (2024) Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma. Cancer Medicine |
Vieira TCRG, Barros CA, Domingues R, et al. (2023) PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry |
Brembati V, Faustini G, Longhena F, et al. (2023) Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease. International Journal of Molecular Sciences. 24 |
Sant'Anna R, Robbs BK, de Freitas JA, et al. (2023) The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis. Molecular Medicine (Cambridge, Mass.). 29: 111 |
Chopra A, Outeiro TF. (2023) Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies. Brain : a Journal of Neurology |
Warth Perez Arias CC, Silbern I, Caldi Gomes L, et al. (2023) Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease. Journal of Neurochemistry. 166: 862-874 |
Flores-Leon M, Outeiro TF. (2023) More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathologica |
Gasparotto J, Somensi N, Girardi CS, et al. (2023) Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry |
Gelain DP, Bittencourt RR, Bastos Mendes LF, et al. (2023) RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions. Journal of Parkinson's Disease |